Bevacizumab Effect on Blood Velocity
NCT01298440 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2011-02-17
Summary
Retinal blood flow velocity is affected by Bevacizump intravitreal injection. This effect is correlated to treatment success.
Conditions
- Choroidal Neovascularization
Sponsors & Collaborators
-
Optical Imaging, Ltd.
lead INDUSTRY
Principal Investigators
-
Adiel Barak, MD · Tel aviv university Sackler school of medicine
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-06-30
Countries
- Israel
Study Locations
More Related Trials
-
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
NCT01256580 ·Status: WITHDRAWN ·Phase: NA
-
Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization
NCT00512876 ·Status: COMPLETED ·Phase: NA
-
Study of the Long-Term Effect of Frequent Anti-VEGF Dosing on Retinal Function in Patients With Neovascular AMD
NCT00533689 ·Status: UNKNOWN ·Phase: PHASE3
-
Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD
NCT00426998 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Intravitreal Avastin Injection for CRVO
NCT01678248 ·Status: UNKNOWN
-
Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration
NCT01027468 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovasculization
NCT00681603 ·Status: COMPLETED ·Phase: NA
-
Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy
NCT00344617 ·Status: UNKNOWN ·Phase: PHASE3
-
Optic Nerve and Retinal Functions With Bevacizumab
NCT01361828 ·Status: COMPLETED
-
Efficacy of Retreatments With Intravitreal Bevacizumab
NCT00406744 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea
NCT01501760 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Bevacizumab for Neovascular Glaucoma
NCT00384631 ·Status: COMPLETED ·Phase: NA
-
IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes
NCT06559488 ·Status: COMPLETED ·Phase: NA
-
Bevacizumab for Central Retinal Vein Occlusion Study
NCT00906685 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
NCT00599820 ·Status: TERMINATED ·Phase: PHASE3
-
Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.
NCT01860586 ·Status: COMPLETED ·Phase: NA
-
Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema
NCT02096874 ·Status: COMPLETED ·Phase: PHASE4
-
Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage
NCT01151722 ·Status: UNKNOWN ·Phase: PHASE2
-
Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)
NCT01327222 ·Status: COMPLETED ·Phase: PHASE3
-
Systemic Avastin Therapy in Age-Related Macular Degeneration
NCT00531024 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD
NCT03744806 ·Status: COMPLETED
-
Corneal Thinning During Topical Bevacizumab Therapy
NCT00515684 ·Status: WITHDRAWN ·Phase: NA
-
The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy
NCT00864773 ·Status: UNKNOWN ·Phase: NA
-
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
NCT00370851 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia
NCT00967850 ·Status: COMPLETED ·Phase: PHASE3